DANIEL M. SCHMITT - President, CEO and Director, Director at ACTUATE THERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO and Director, Director
Issuer Symbol
ACTU on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by DANIEL M. SCHMITT since 12 Mar 2025

Holdings reported by DANIEL M. SCHMITT for ACTUATE THERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 564,071 $3,756,712 $6.66 13 Feb 2026 By The Schmitt Family Irrevocable Trust, dated December 31, 2019
Common Stock 150,181 $650,283 $4.33 13 Feb 2026 Direct
Common Stock 22,223 $148,005 $6.66 13 Feb 2026 By The Andrew Schmitt Irrevocable Trust, dated December 31, 2019
Common Stock 22,223 $148,005 $6.66 13 Feb 2026 By The Anna Schmitt Irrevocable Trust, dated December 31, 2019
Common Stock 22,223 $148,005 $6.66 13 Feb 2026 By The Edward Schmitt Irrevocable Trust, dated December 31, 2019
Restricted Stock Units 272,056 13 Feb 2026 Direct Common Stock
Employee Stock Option (right to buy) 204,285 01 Apr 2025 Direct Common Stock

Transactions reported by DANIEL M. SCHMITT for ACTUATE THERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.